X0202 4 2004-10-15 0 0001138812 COTHERIX INC CTRX 0001276361 ALTA PARTNERS II INC ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001106287 GRUENER GARRETT ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198328 MARDUEL ALIX ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198330 NOHRA GUY P ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2004-10-15 4 C 0 1862546 0.00 A 2004837 I See footnote Common Stock 2004-10-15 4 C 0 1363200 0.00 A 1363200 I See footnote Common Stock 2004-10-15 4 P 0 416666 6.00 A 2421503 I See footnote Series B Preferred Stock 0.00 2004-10-15 4 C 0 715481 0.00 D Common 715481 0 I See footnotes Series C Preferred Stock 0.00 2004-10-15 4 C 0 1147065 0.00 D Common 1147065 0 I See footnotes Series C Preferred Stock 0.00 2004-10-15 4 C 0 1363200 0.00 D Common 1363200 0 I See footnotes Not applicable Upon the effective date of the Issuer's IPO: Alta California Partners III, L.P. ("ACPIII") shares converted into 1,804,891 shares of Common Stock and Alta Embarcadero Partners III, LLC ("AEPIII") shares converted into 57,655 shares of Common Stock. Daniel Janney, Director, is a managing director of Alta California Managment Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII") & a manager of Alta Embarcadero Partners III, LLC ("AEPIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEPIII. He is a member of Alta BioPharma Managment III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of their proportionate pecuniary interests therein. Alta Partners II, Inc. provides investment advisory services to several funds including ACPIII, AEPIII, ABPIII, Alta BioPharma Partners III GmbH & Co. Beteilgungs KG ("ABPIIIKG") & Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The respective managing directors ("md") of ABMPIII (which is the general partner of ABPIII & ABPIIIKG) & managers of AEPIII, exercise sole voting & investment power with respect to the shares owned by such funds. G. Gruener, G. Nohra & D. Janney (collectively known as the "principals") are md of ACMPIII & members of AEPIII. J. Deleage, F. Champsi, E. Hurwitz & E. Penhoet (collectively known as the "principals") are directors of ABMPIII (which is the gp of ABPIII & ABPIIIKG & managers of AEBPIII, The principals may be deemed to share voting & investment powers over the shares held by the funds. The principals disclaim beneficial ownership of all such shares held by the funds, except to the extent of their porportionate pecuniary interest therein. Upon the effective date of the Issuer's IPO: Alta BioPharma Partners III, L.P. shares converted into 1,242,942 shares of Common Stock, Alta BioPharma Partners III GmbH & Co. Beteiligungs KG shares converted into 112,054 shares of Common Stock, and Alta Embarcadero BioPharma Partners III, LLC shares converted into 8,204 shares of Common Stock. At the Issuer's IPO, Alta California Partners III, L.P. purchased 416,666 shares of Common Stock. Reflects 1:0.606 reverse stock split and the conversion adjustment of 1.0626 for Series B Preferred Stock. Series B Preferred Stock: Alta California Partners III, L.P. beneficially owns 695,371 shares and Alta Embarcadero Partners III, LLC beneficially owns 20,110 shares. Immediately Series C Preferred Stock: Alta California Partners III, L.P. beneficially owns 1,109,597 shares and Alta Embarcadero Partners III, LLC beneficially owns 37,468 shares. Reflects 1:0.606 reverse stock split and the conversion adjustment of 1.0686 for the Series C Preferred Stock. Series C Preferred Stock: Alta BioPharma Partners III, L.P. beneficially owns 1,242,942 shares and Alta BioPharma Partners III GmbH & Co. Beteiligungs KG beneficially owns 112,054 shares, and Alta Embarcadero BioPharma Partners III, LLC benefically owns 8,204 shares. Cross-reference to Form 4 for Daniel Janney filed on 10/19/2004 Jean Deleage, President of Alta Partners II, Inc. 2004-10-19 Jean Deleage 2004-10-19 Garrett Gruener 2004-10-19 Alix Marduel 2004-10-19 Guy Nohra 2004-10-19 Farah Champsi 2004-10-19